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A B S T R A C T
This meta-analysis evaluated the use of potential dietary feed additives (pDFA) with antibacterial effects
and their impact on the perfomance of weaned piglets. Twenty-three peer-reviewed in vivo studies,
comprising 50 trials, were identiﬁed between January 2010 and January 2017. The pDFA in these studies
could be grouped in 5 classes: antimicrobial peptides, chitosan, lysozyme, medium chain fatty acids/
triglycerides and plant extracts. Mixed-effect meta-analyses with type of pDFA as ﬁxed effect were
performed for the growth parameters ‘average daily gain’ (ADG) and ‘feed conversion ratio’ (FCR), which
are the two most important and used economic performance parameters for farmers.
For each class of pDFA, results of the meta-analysis showed signiﬁcantly higher average daily gain in
the group with pDFA compared to the negative control group, while no signiﬁcant difference with the
positive control group was observed. Furthermore, a positive effect on FCR was found, i.e. signiﬁcantly
less feed was needed to gain 1 kg of body weight in the group with pDFA compared to the negative control
group. No signiﬁcant differences with positive control groups were observed for each class of pDFA,
except for plant extracts, where the FCR was also signiﬁcantly reduced in the treatment group. These
results suggest that pDFA could reduce the use of antimicrobials without signiﬁcant negative effects on
performance indicators.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In contrast to weaning in nature, domestic piglets are usually
weaned abruptly between 3 and 4 weeks of age by separating them
from the sow. The piglets face stressors such as changes in the diet,
in the social environments and in physical environments (Weary
et al., 2008). These stress factors and resulting histological changes
in the small intestine may negatively affect the response of the
immune system and lead to an intestinal gut dysfunction in pigs
(McCracken et al., 1999; Lallès et al., 2004, 2007).
Pig production practices are often associated with regular use of
antimicrobials (AMUs), such as colistin and amoxicillin to maintain
health and productivity during these periods (Callens et al., 2012;
Sjölund et al., 2016). AMUs contribute to an increasing selection
pressure on bacteria to become resistant (Chantziaras et al., 2014).* Corresponding author.
E-mail address: info@nutrition-sciences.com (G. Bruggeman).
https://doi.org/10.1016/j.tvjl.2019.04.017
1090-0233/© 2019 The Authors. Published by Elsevier Ltd. This is an open access article unBoth by under-dosing or by correct dosing, AMUs provoke the
selection and spread of acquired resistances in bacteria. By co-
selection (co-resistance or cross-resistance), bacteria can also
become resistant to other (similar) AMUs. The development of
antimicrobial resistance in veterinary medicine causes therapy
failure in animals, resulting in a reduced productivity, loss of
animals, decreased animal welfare and increased production costs.
In human medicine, problems may arise because resistant
bacteria can be transferred from animals to humans (Da Costa
et al., 2013; Tang et al., 2017). In humans, colistin is now considered
as one of the last therapeutic options for the treatment of
infections caused by multidrug-resistant Gram-negative bacteria
(Walkty et al., 2009; Michalopoulos et al., 2011; Callens et al., 2016;
Rhouma et al., 2017). Studies have reported the isolation of
colistin-resistant Escherichia coli (E. coli) from pigs (Boyen et al.,
2010; Morales et al., 2012), up to 35% in some countries (Harada
et al., 2005). Food producing animals, particularly pigs, have been
singled out as the most potential reservoirs for the spread and
ampliﬁcation of colistin resistance (Nordmann and Poirel, 2017).der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Medicine Agency (EMA) have recommended reducing the use of
colistin in animal production and to restrict its use to the treatment
of sick animals as a last resort option (European Medicines Agency,
2016). From November ﬁrst, 2016 colistin was banned to be used as
a growth promotor in China (Walsh and Wu, 2016).
These problems call for initiatives to preserve antibiotic
effectiveness. In general, it is considered that reduction of AMU
use and responsible AMU use will result in a decrease of the
occurrence of antimicrobial resistance. Reduction of AMU use
mainly means that in general, the antibiotic use must be
diminished, thinking in the ﬁrst place of prophylactic group
treatments. Prevention of illnesses by an ameliorated biosecurity,
management, vaccination plans, but also nutrition will have to
become more important (Postma et al., 2015). As the selection for
resistance is linked to the level of AMU, the reversion to
susceptibility is equally linked to the reduction in selection
pressure. Several studies have shown that reducing AMU use is
indeed translated in a reduced level of resistance (Dorado-García
et al., 2016; Callens et al., 2018).
A number of alternatives/replacements for antibiotics have been
proposed (Seal et al., 2013) such as dietary feed additives (pDFA) or
zinc oxide (ZnO). However, a concern with feeding pharmacological
levels of ZnO to pigs is that application of manure containing high
levels of ZnO to agricultural lands has the potential to negatively
impact the environment and therefore are highly debated (Jensen
et al., 2018). As a result, the European commission issued a decision
on June 26, 2017 to withdraw the marketing authorizations of ZnO
derivatives at the latest ﬁve years from this date. Moreover, there are
evidences on the role of ZnO in co-selecting resistant bacteria
(Vahjen et al., 2015). Currently, a wide variety of pDFA such as
immunity modulating agents, bacteriophages and their lysins,
antimicrobial peptides, pro-, pre-, and synbiotics, plant extracts,
inhibitors targeting pathogenicity (bacterial quorum sensing,
bioﬁlm, and virulence), enzymes and others show beneﬁcial effects
around weaning (Cheng et al., 2014). However, there exists
scepticism on how effective these pDFA are and if they can replace
antibiotics around weaning. From a wide range of pDFA, a possible
antimicrobial mode of action was already evaluated in vitro. Yet, the
in vivo effect cannot be automatically extrapolated from these in
vitro studies due to possible degradation, inactivation and/or
inhibition in the gastro-intestinal tract. Therefore, this meta-analysis
combines the results of in vivo trials which tested a weaning diet
containing antibiotics versus pDFA with an antimicrobial mode of
action, based on the two most occurring performance indicators:
ADG and FCR. It should be noted that other perfomance indicatorsFig. 1. Design of the literature review basedexist, such as the frequency of diarrhea and medication, that are not
included in thismeta-analysis,duetothe limiteddata available inthe
consulted literature.
Materials and methods
The literature database of Web Of Knowledge was used for this meta-analysis
(Fig. 1). The search terms were initially: ‘pig’ + ‘antimicrobial’ or ‘antibacterial’, in
addition there was a search on: ‘pig’ + ‘essential oil’, ‘plant extracts’, ‘lysozyme’,
‘fatty acids’, ‘plasma’, ‘IgY’, ‘egg yolk’. The following boundaries were set: the trials
had to be performed on weaned piglets, where the performance of a diet containing
a pDFA, with shown antimicrobial action in vitro, is compared to a diet containing
antibiotics, if applicable the negative control diet was also included. The database
was consoled from January 2010 until January 2017 (1631 studies), since trials
before 2010 were often designed to replace antimicrobial growth promoters
(AGP’s), while this review focusses more on the replacement of therapeutic
antibiotics. Performance indicators are collected at start and end of the trial and
signiﬁcant differences were recorded. For each trial, the dose of pDFA and the
antibiotic was noted, together with number of pigs per group, weaning age and
weight, trial days and if the pigs were artiﬁcially challenged. The growth parameters
(ADG and FCR) for the trials were noted and signiﬁcant changes were indicated. For
each pDFA, the relative differences were calculated for ADG and FCR.
DerSimonian-Laird mixed effects meta-analyses with type of pDFA as ﬁxed
effect were performed for the growth parameters ADG and FCR with the ‘metafor’
package in R version 3.3.1 (https://cran.r-project.org). For each growth parameter,
pDFA was compared with the negative control group on the one hand and with the
positive control group on the other hand. Forest plots were created to visualize the
mean differences with corresponding 95% conﬁdence intervals (95% CI).
The growth parameter FCR was deﬁned as the amount of feed intake to gain 1 kg
of body weight (ratio of feed intake and body weight gain). In some trials, feed
efﬁciency was deﬁned as the ratio of weight gain and feed intake. To obtain FCR as
deﬁned above, the inverse of the weight gain/feed intake ratio was taken and the
variance was estimated with the delta method as follows:
Var
feed intake
weight gain
 
¼ 1
weight gain

feed intake
 4  Varðweight gain=feed intakeÞ
Results
A total of 23 studies met the above criteria comprising a total of
50 trials (Table 1; Huang et al., 2010, 2011; Henn et al., 2010; Han
et al., 2011; Hong et al., 2012; Li et al., 2012; May et al., 2012;
Nyachoti et al., 2012; Tang et al., 2012, 2013, 2016; Wu et al., 2012;
Yang et al., 2012; Ahmed et al., 2013; Oliver and Wells, 2013;
Robbins et al., 2013; Oliver et al., 2014; Yoon et al., 2014; Gois et al.,
2016; Long et al., 2016; Peng et al., 2016; Sbardella et al., 2016; Wan
et al., 2016). Two trials were excluded, i.e. Tang et al. (2013) and
Tang et al. (2016). These trials showed a very low daily growth for
the control piglets, resulting from working with challenged piglets,
which made the comparison with the other studies difﬁcult. on the database of Web Of Knowledge.
Table 1
The overview of the experiments included in this meta-analysis.
Reference Type of pDFA Antimicrobial Compound Dosage
(%)
Negative
control
Positive control Comments
Yoon et al. (2014) AMP AMP-A3 0.006 0.015% avilamycin
Yoon et al. (2014) AMP AMP-P5 0.006 0.015% avilamycin
Peng et al. (2016) AMP Beta-defensin 2 0.1 No 1.5% crude P. pastoris X-33 + 200 mg 10%
colistin sulfate + 1.0 mg 10% zinc
bacitracin/kg
Peng et al. (2016) AMP Beta-defensin 2 0.5 No 1.5% crude P. pastoris X-33 + 200 mg 10%
colistin sulfate + 1.0 mg 10% zinc
bacitracin/kg
Peng et al. (2016) AMP Beta-defensin 2 1.5 No 1.5% crude P. pastoris X-33 + 200 mg 10%
colistin sulfate + 1.0 mg 10% zinc
bacitracin/kg
Tang et al. (2016) AMP Beta-defensin 2 0.01
(in
water)
0.06% Neomycin (in water) ETEC2 0149:K88
Tang et al. (2013) AMP Buferin 0.005
(in
water)
0.005% colistin sulfate (in water) ETEC 0149 0141 0164
Wu et al. (2012) AMP Cecropin AD 0.04 0.01% Kitasamycin + 0.08% colistin
sulfate
Wu et al. (2012) AMP Cecropin AD 0.04 0.01% Kitasamycin + 0.08% colistin
sulfate
ETEC K88
Tang et al. (2012) AMP Lactoferricin 0.01 0.01% chlortetracycline ETEC 0149 0141 0164
Wan et al. (2016) AMP Plectasin 0.006 0.006% colistin sulfate
Yang et al. (2012) Chitosan Chito-oligosacharide 0.02 0.002% colistin sulfate
Yang et al. (2012) Chitosan Chito-oligosacharide 0.04 0.002% colistin sulfate
Yang et al. (2012) Chitosan Chito-oligosacharide 0.06 0.002% colistin sulfate
Oliver and Wells (2013) Lysozyme Lysozyme 0.01 0.0055% carbadox + 0.025% Cu
May et al. (2012) Lysozyme Lysozyme 0.01 0.0016% neomycin and oxytetracycline
Nyachoti et al. (2012) Lysozyme Lysozyme 0.1a 0.25% chlortetracycline, sulfamethazine
and penicillin
Nyachoti et al. (2012) Lysozyme Lysozyme 0.1a 0.25% chlortetracycline, sulfamethazine
and penicillin
ETEC
Nyachoti et al. (2012) Lysozyme Lysozyme 0.2a 0.25% chlortetracycline, sulfamethazine
and penicillin/kg of feed
Nyachoti et al. (2012) Lysozyme Lysozyme 0.2a 0.25% chlortetracycline, sulfamethazine
and penicillin/kg of feed
ETEC
Long et al. (2016) Lysozyme Lysozyme 0.003 0.002% colistin sulphate + 0.005%
kitasamycin
Long et al. (2016) Lysozyme Lysozyme 0.006 0.002% colistin sulphate + 0.005%
kitasamycin
Long et al. (2016) Lysozyme Lysozyme 0.009 0.002% colistin sulphate + 0.005%
kitasamycin
Long et al. (2016) Lysozyme Lysozyme 0.012 0.002% colistin sulphate + 0.005%
kitasamycin
Oliver et al. (2014) Lysozyme Lysozyme 0.01 0.0055% Chlortetracylcine + 0.165%
Denagard (Tiamulin hydrogen
fumarate)
Clean nursery
Oliver et al. (2014) Lysozyme Lysozyme 0.01 0.0056% Chlortetracylcine + 0.165%
Denagard (Tiamulin hydrogen
fumarate)
Dirty nursery
Han et al. (2011) MC FA/T MCFA
(Eucalyptus)
0.1 0.0033% tiamulin + 0.0044% lincomycin
Han et al. (2011) MC FA/T MCFA
(Eucalyptus)
0.1 0.0033% tiamulin + 0.0044% lincomycin
Han et al. (2011) MC FA/T MCFA
(Eucalyptus)
0.1 No 0.0033% tiamulin + 0.0044% lincomycin
Hong et al. (2012) MC FA/T MCT 0.32 0.004% tiamulin + 110 ppm
tylosin + 0.001% enramycin
Hong et al. (2012) MC FA/T MCT 0.55 0.004% tiamulin + 110 ppm
tylosin + 0.001% enramycin
Hong et al. (2012) MC FA/T MCT 0.32 0.004% tiamulin + 110 ppm
tylosin + 0.001% enramycin
Hong et al. (2012) MC FA/T MCT 0.55 0.004% tiamulin + 110 ppm
tylosin + 0.001% Enramycin
Huang et al. (2011) Plant ex. Allicin 0.0025 No 0.0075% aureomycin + 0.01% arsanilic
acid + 0.002% colistin sulphate
Huang et al. (2011) Plant ex. Allicin 0.00375 No 0.0075% aureomycin + 0.01% arsanilic
acid + 0.002% colistin sulphate
Huang et al. (2011) Plant ex. Allicin 0.005 No 0.0075% aureomycin + 0.01% arsanilic
acid + 0.002% colistin sulphate
Huang et al. (2011) Plant ex. Allicin 0.00625 No 0.0075% aureomycin + 0.01% arsanilic
acid + 0.002% colistin sulphate
Huang et al. (2010) Plant ex. Cinnamaldehyde + carvacrol +
eugenol + thymol + eugenol
0.1 44 ppm tylosin/kg
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Table 1 (Continued)
Reference Type of pDFA Antimicrobial Compound Dosage
(%)
Negative
control
Positive control Comments
Ahmed et al. (2013) Plant ex. Essential oil blend 0.0125 0.002% apramycin KCTC 2571b and Sal.
Enterica srover
Typhimurium
Sbardella et al. (2016) Plant ex. Hops beta-acids 0.012 0.004% colistin
Sbardella et al. (2016) Plant ex. Hops beta-acids 0.024 0.004% colistin
Sbardella et al. (2016) Plant ex. Hops beta-acids 0.036 0.004% colistin
Henn et al. (2010) Plant ex. Oregano oil 0.003 0.5% zinc oxide + 0.05% zinc bacitracin
Robbins et al. (2013) Plant ex. Quaternary benzo(c)
phenanthridine alkaloid
0.00015 0.00594% chlortetracycline
Robbins et al. (2013) Plant ex. Quaternary benzo(c)
phenanthridine alkaloid
0.000075 0.00594% chlortetracycline
Gois et al. (2016) Plant ex. Red pepper oil 0.05 0.012% chlorohydroxyquinoline
Gois et al. (2016) Plant ex. Red pepper oil 0.1 0.012% chlorohydroxyquinoline
Gois et al. (2016) Plant ex. Red pepper oil 0.15 0.012% chlorohydroxyquinoline
Ahmed et al. (2013) Plant ex. Resveratrol 0.2c 0.002% apramycin KCTC 2571b and Sal.
Enterica srover
Typhimurium
Li et al. (2012) Plant ex. Thymol + Cinnamaldehyde 0.0018 0.015% Chlortetracycline + 0.008%
Colistin sulfate + 0.005% Kitasamycin
AMP, Antimicrobial peptides; ETEC, Escherichia coli; Plant ex, Plant extract.
a 0.1% based on the content of the product Entegard (4000 lysozyme units/mg) in experimental diet.
b KCTC 2571: Escherichia coli KCTC 2571.
c 0.2% based on the content of the product Respig (detailed composition not shown).
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groups: anti-microbial peptides (AMP), chitosan, lysozyme,
medium chain fatty acids or triglycerides (MC FA/T) and
plant extracts (Table 1). Plant extracts and AMP are pDFA
containing a wide variety of pDFA, while lysozyme is a single
pDFA.Fig. 2. This forest plot shows the results of the mixed effects meta-analysis with type of p
(ADG, in g) the mean difference estimate (black square symbol) with corresponding 95% 
the negative control group is shown. Whenever a 95% CI exceeded the plot limits of (150
model is shown in grey, with the outer edges of the polygon indicating the 95% CI limThere exists a vast amount of other pDFA like porcine plasma,
immunized egg yolk, etc. that are not included in this review due to
the restrictions in selection. Some researchers are also very
cautious to proclaim antimicrobial action as it is not easy to
conﬁrm bactericidal effect in vivo and often chose to address the
growth promoting effect.otential dietary feed additive (pDFA) as ﬁxed effect. For the average daily weight gain
conﬁdence interval (95% CI; black bar) between the treatment group with pDFA and
; 150), this was indicated by an arrow. Per pDFA the summary estimate based on the
its.
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In six trials with AMPs, ADG was on average 22 g (95% CI 13, 32)
higher compared to the negative control group (Fig. 2), while in 9
trials overall no signiﬁcant difference with the positive control
group was observed (95% CI 13, 13; Fig. 3). Regarding FCR, on
average 96 g (95% CI 52, 140) less feed was needed in the treatment
group compared to the negative control group to gain 1 kg of body
weight (Fig. 4), while overall no signiﬁcant difference with the
positive control group was observed (95% CI 51, 48; Fig. 5).
Chitosan
There were only three trials from one study with chitosan. ADG
was on average 34 g (95% CI 9, 59) higher compared to the negative
control group (Fig. 2), while overall no signiﬁcant difference with
the positive control group was observed (95% CI 44, 20; Fig. 3). On
average 142 g (95% CI 62, 221) less feed was needed in the
treatment group compared to the negative control group to gain
1 kg of body weight (Fig. 4), while overall no signiﬁcant difference
with the positive control group was observed (95% CI 148, 47);
Fig. 5).Fig. 3. This forest plot shows the results of the mixed effects meta-analysis with type of p
(ADG, in g) the mean difference estimate (black square symbol) with corresponding 95% 
the positive control group is shown. Whenever a 95% CI exceeded the plot limits of (150
model is shown in grey, with the outer edges of the polygon indicating the 95% CI limLysozyme
In 12 trials with lysozyme, ADG was on average 28 g (95% CI 17,
40) higher compared to the negative control group (Fig. 2), while
overall no signiﬁcant difference with the positive control group
was observed (95% CI 28, 4; Fig. 3). On average 52 g (95% CI 7,
97) less feed was needed in the treatment group compared to the
negative control group to gain 1 kg bodyweight (Fig. 4), while
overall no signiﬁcant difference with the positive control group
was observed (95% CI 88, 25; Fig. 5).
Medium chain fatty acids or triglycerides
In 6 trials with MC FA/T, ADG was on average 28 g (95% CI 12, 43)
higher compared to the negative control group (Fig. 2), while in 7
trials overall no signiﬁcant difference with the positive control
group was observed (95% CI 10, 32; Fig. 3). On average 79 g (95%
CI 15, 143) less feed was needed in the treatment group compared
to the negative control group to gain 1 kg of body weight (Fig. 4),
while overall no signiﬁcant difference with the positive control
group was observed (95% CI 89, 68; Fig. 5).otential dietary feed additive (pDFA) as ﬁxed effect. For the average daily weight gain
conﬁdence interval (95% CI; black bar) between the treatment group with pDFA and
; 150), this was indicated by an arrow. Per pDFA the summary estimate based on the
its.
Fig. 4. This forest plot shows the results of the mixed effects meta-analysis with type of potential dietary feed additive (pDFA) as ﬁxed effect. For the feed conversion ratio
(FCR) the mean difference estimate (black square symbol) with corresponding 95% conﬁdence interval (95% CI; black bar) between the treatment group with pDFA and the
negative control group is shown. Per pDFA the summary estimate based on the model is shown in grey, with the outer edges of the polygon indicating the 95% CI limits.
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In 13 trials with plant extracts and essential oils, ADG was on
average 32 g (95% CI 14; 50) higher compared to the negative
control group (Fig. 2), while in 17 trials overall no signiﬁcant
difference with the positive control group was observed (95% CI
6, 22; Fig. 3). On average 79 g (95% CI 30, 128) less feed was
needed in the treatment group compared to the negative control
group to gain 1 kg of body weight (Fig. 4). Compared to the positive
control group, on average 75 g (95% CI 27,123) less feed was needed
in the treatment group to gain 1 kg of body weight (Fig. 5).
Discussion
This comprehensive meta-analysis provides a very valuable and
balanced overview of the available literature on the effects of pDFA
in weaned piglets on the performance parameters ADG and FCR. As
mentioned before, the pDFA used in the selected trials could be
classiﬁed in 5 groups, which will be discussed below.
Anti-microbial peptides are small biological molecules
(<10 kDa) with a broad-spectrum activity against bacteria, fungi,
protozoa and some viruses (Lai and Gallo, 2009). Anti-microbial
peptides exert multiple antimicrobial activities that might provide
a strategy to prevent bacteria from developing resistance (Peschel
and Sahl, 2006). Anti-microbial peptides are potential alternatives
to conventional antibiotics due to their broad-spectrum of activity,
low level of induced resistance, and immunomodulatory proper-
ties (Peng et al., 2016). The literature review demonstrates that the
AMPs have a beneﬁcial effect on the ADG and FCR in comparison to
non-treated groups. In comparison to AMU treatments, the results
of the AMP groups are not signiﬁcantly different. These results
indicate that overall the AMPs may have potential to serve assubstitutes to feed AMUs without jeopardising the production
results.
Chitosan is obtained from the shell water of industries
processing crab, shrimp, and crawﬁsh, and can be used in animal
diets due to its antimicrobial property (Singla and Chawla, 2001).
Chito-oligosaccharides (COS) are the degraded products of
chitosan or chitin prepared by enzymatic or chemical hydrolysis
of chitosan. The solubility and low viscosity of COS have attracted
the interest to utilize COS and their derivatives for various
biomedical applications (Lodhi et al., 2014) and as alternative to
feed-grade antibiotics (Yang et al., 2012). Although few trials were
available using chitosan, it is clear from these trials that they have
potential. In comparison to non-treated groups, chitosan positively
effects the ADG and FCR, while no signiﬁcant difference was
observed in comparison to a treatment with AMUs.
Lysozyme is a naturally occurring enzyme, and functions as
an anti-microbial by cleaving the glycosidic linkage of bacterial
cell walls peptidoglycan (Ellison and Giehl, 1991). Lysozyme is
an important defence mechanism and is considered a part of
the innate immune system in most mammals. Lysozyme is
rather ineffective against Gram-negative bacteria due to the
outer membrane barrier that surrounds and protects the
peptidoglycan layer (Varahan et al., 2013). Also in the case of
lysozyme, our meta-analysis shows the promising capacity to
improve ADG and FCR compared to a negative control.
Compared to a positive control with AMUs, no signiﬁcant
effect could be observed.
Medium chain fatty acids or triglycerides are organic acids with
6 to 12 carbon atoms. The mechanism(s) underlying the
bactericidal activity of MC FA/T is not fully understood; however,
many studies suggest that they act as nonionic surfactants, which
become incorporated into the bacterial cell membrane (Bergsson
Fig. 5. This forest plot shows the results of the mixed effects meta-analysis with type of potential dietary feed additive (pDFA) as ﬁxed effect. For the feed conversion ratio
(FCR) the mean difference estimate (black square symbol) with corresponding 95% conﬁdence interval (95% CI; black bar) between the treatment group with pDFA and the
positive control group is shown. Whenever a 95% CI exceeded the plot limits of (0.50; 1.00), this was indicated by an arrow. Per pDFA the summary estimate based on the
model is shown in grey, with the outer edges of the polygon indicating the 95% CI limits.
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also show that MC FA/T diffuse through the bacterial cell
membrane and create transient or permanent pores, resulting in
altered membrane permeability and cell death (Bergsson et al.,
2001; Altieri et al., 2009; Desbois and Smith, 2010). The
mechanisms underlying the bactericidal activity mediated by
weak organic acids have been widely investigated. Un-dissociated
organic acids penetrate the cell membrane and enter the
cytoplasm, where they dissociate into charged anions and protons,
thereby altering the hydrogen ion equilibrium inside the cell and
raising the pH (Brul and Coote, 1999). From our meta-analysis, a
similar conclusion could be drawn as compared to the previous
pDFA. Medium chain fatty acids or triglycerides show the
possibility to improve ADG and FCR compared to a negative
control. In contrast, no signiﬁcant effect could be observed
compared to a positive treatment with AMUs.
Plant extracts and essential oils act along the animal digestive
tract to improve appetite and modulate the microbiota, and are
able to induce a number of other beneﬁts (Franz et al., 2010). The
antimicrobial properties of essential oils and extracts can be dose-
dependently bacteriostatic and/or bactericidal. Several investiga-
tions have also shown their antioxidant effect, their effects on
digestive physiology and digestion at weaning (Zabielski et al.,
1999) and on the microbiology of the gut (Franz et al., 2010). From
the amount of trials using plant extracts (17 out of 50), it is clearthat they are most explored from all selected pDFA in this meta-
analysis. Besides having a positive effect compared to a negative
control, plant extracts also showed the capacity to improve FCR in
comparison to a positive treatment with antimicrobials. However,
ADG was not signiﬁcantly different compared to a positive
treatment.
Conclusions
Between January 2010 and January 2017, 23 in vivo studies
(comprising 50 trials) were published that evaluated the use of
pDFA against a positive control diet with antibiotics in weaned
piglets, and reporting the performance parameters ADG and FCR.
The results of the meta-analysis clearly show that adding a pDFA at
weaning can improve performance indicators compared to an
untreated group (negative control), suggesting that pDFA could
increase growth and improve feed conversion. As such, pDFA could
potentially enhance production without the negative side effect of
AMUs.
Compared to the use of AMUs (positive control), the results of
the meta-analysis show no overall signiﬁcant difference. This is a
beneﬁcial result, as it suggests that the use of AMUs around
weaning, a very commonly used practice, could be replaced by
pDFA without signiﬁcant negative effects on the performance
indicators.
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